BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 10, 2011
View Archived Issues
GSK and Theravance provide update on new treatments for COPD
Read More
Cepheid and FIND collaborate on Xpert HIV viral load test
Read More
PharmaMar begins phase I trial of antitumor agent PM-060184
Read More
Phase II data presented on tasocitinib in plaque psoriasis
Read More
Expression levels of miR-21 and RHOB gene have prognostic value in urinary bladder cancer
Read More
Anti-inflammatory agents enhance effects of tazarotene on comedonal acne
Read More
Heterosubtypic influenza A vaccine is safe and immunogenic in healthy adults
Read More
EV-075 has potent activity against influenza and Ebola/Marburg viruses in vivo
Read More
Merck Serono presents new prostanoid DP2 receptor ligands
Read More
FDA clears Medicago's phase I trial of H1N1 influenza VLP vaccine candidate
Read More
AstraZeneca to withdraw NDA for anticancer drug Iressa
Read More
Tacere Therapeutics reacquires Asian rights to RNAi-based agents targeting HCV
Read More
Takeda begins enrollment in phase III alogliptin study in China
Read More
European phase IIb study of Posidur meets primary endpoints
Read More
Nerviano Medical Sciences divulges new PARP-1 inhibitors
Read More
New PI3K inhibitors developed at Incyte
Read More
Daiichi Sankyo patents novel tachykinin receptor antagonists
Read More
QLT stops phase II trial of olopatadine punctal plug delivery system
Read More
Japanese scientists claim new inhibitors of kinesin-like protein KIF11
Read More
INTRUST trials of Novartis' Onbrez Breezhaler plus tiotropium meet primary endpoints
Read More
Kyowa Hakko Kirin offers overview of 2010
Read More
Phase IIb trial of AM-101 in acute inner ear tinnitus completes enrollment
Read More
Idenix Pharma reports on three clinical programs
Read More
FDA grants orphan status to Neuralstem for spinal cord stem cells in ALS
Read More